Axcella Health Inc. (NASDAQ:AXLA) finished Friday with a subtraction of -$0.02 to close at $0.11, a downside of -12.77 percent. An average of 12,342,561 shares of common stock have been traded in the last five days. There was a fall of -$0.0465 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 3,179,195 shares traded, while the 50-day average volume stands at 1,518,316.
AXLA stock has decreased by -42.11% in the last month. The company shares reached their 1-month lowest point of $0.1035 on 08/25/23. With the stock rallying to its 52-week high on 01/26/23, shares of the company touched a low of $0.12 and a high of $2.70 in 52 weeks. It has reached a new high 8 times so far this year and lost -66.41% or -$0.2175 in price. In spite of this, the price is down -95.93% from the 52-week high.
Insider Transactions
AXLA stock investors should be aware that Axcella Health Inc. (AXLA) stock had its last reported insider trading activity 178 days ago on Mar 01. In this transaction, the insider spent $394. President & CEO, Hinshaw William, disposed of 16,000 shares at a price of $1.56 on Oct 19. The insider now owns more than $25,027 worth of shares. Prior to that, Chief Medical Officer Koziel Margaret went on to Sale 547 shares at $2.52 each on Sep 06. An amount of $1,378 was transacted.
Financial Health
The quick ratio of Axcella Health Inc. for the three months ended June 29 was 0.80, and the current ratio was 0.80, indicating that the company is not able to meet its debt obligations. Its gross profit as reported stood at $3.02 million compared to revenue of $76.99 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Axcella Health Inc.’s return on assets was -268.80%.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$3.41 million in the quarter, while revenues of -$3.98 million were shrunk -524.93%. The analyst consensus anticipated Axcella Health Inc.’s latest quarter earnings to come in at -$0.06 per share, but it turned out to be -$0.05, a 16.70% surprise. For the quarter, EBITDA amounted to -$3.53 million. Shareholders own equity worth $73.69 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Axcella Health Inc. (AXLA) price momentum. RSI 9-day as of the close on 25 August was 22.41%, suggesting the stock is oversold, with historical volatility in this time frame at 138.43%.
As of today, AXLA’s price is $0.1460 -29.71% or -$0.0465 from its 5-day moving average. AXLA is currently trading -40.22% lower than its 20-day SMA and -75.70% lower than its 100-day SMA. However, the stock’s current price level is -63.82% below the SMA50 and -87.75% below the SMA200.
The stochastic %K and %D were 4.26% and 10.13%, respectively, and the average true range (ATR) was 0.0310. With the 14-day stochastic at 3.21% and the average true range at 0.0290, the RSI (14) stands at 26.30%. The stock has reached -0.0252 on the 9-day MACD Oscillator while the 14-day reading was at -0.0320.
Analyst Ratings
Noble Capital Markets launched coverage on Axcella Health Inc. (NASDAQ: AXLA) in its analyst report released on October 12, 2021. The firm assigned the stock an Outperform rating. The consensus rating for Axcella Health Inc. (AXLA) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AXLA, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.
What is AXLA’s price target for the next 12 months?
Analysts predict a range of price targets between $1.50 and $1.50, with a median target of $1.50. Taking a look at these predictions, the average price target given by analysts for Axcella Health Inc. (AXLA) stock is $1.50.
